Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 4
2006 2
2007 3
2008 3
2009 2
2010 3
2011 6
2012 5
2013 4
2014 5
2015 8
2016 8
2017 11
2018 10
2019 5
2020 11
2021 8
2022 9
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Dimetindene-Is the minimum toxic dose for children too strict?
Čečrle M, Pelclová D, Tomáš N, Zacharov S. Čečrle M, et al. Among authors: tomas n. Basic Clin Pharmacol Toxicol. 2024 May;134(5):750-755. doi: 10.1111/bcpt.14005. Epub 2024 Mar 23. Basic Clin Pharmacol Toxicol. 2024. PMID: 38520199
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Sarkisian SR Jr, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Kothe AC, Usner DW, Katz LJ, Navratil T; GC-010 Travoprost Intraocular Implant Investigators. Sarkisian SR Jr, et al. Among authors: navratil t. Ophthalmology. 2024 Feb 27:S0161-6420(24)00161-1. doi: 10.1016/j.ophtha.2024.02.022. Online ahead of print. Ophthalmology. 2024. PMID: 38423216
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial.
Sarkisian SR, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Applegate D, Kothe AC, Usner DW, Katz LJ, Navratil T. Sarkisian SR, et al. Among authors: navratil t. Ophthalmol Ther. 2024 Apr;13(4):995-1014. doi: 10.1007/s40123-024-00898-y. Epub 2024 Feb 12. Ophthalmol Ther. 2024. PMID: 38345710 Free PMC article.
Elevated glutathione in researchers exposed to engineered nanoparticles due to potential adaptation to oxidative stress.
Klusackova P, Lischkova L, Kolesnikova V, Navratil T, Vlckova S, Fenclova Z, Schwarz J, Ondracek J, Ondrackova L, Kostejn M, Dvorackova S, Rossnerova A, Pohanka M, Bradna P, Zdimal V, Pelclova D. Klusackova P, et al. Among authors: navratil t. Nanomedicine (Lond). 2024 Feb;19(3):185-198. doi: 10.2217/nnm-2023-0207. Epub 2024 Jan 26. Nanomedicine (Lond). 2024. PMID: 38275177 Free article.
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Berdahl JP, Sarkisian SR Jr, Ang RE, Doan LV, Kothe AC, Usner DW, Katz LJ, Navratil T; Travoprost Intraocular Implant Study Group. Berdahl JP, et al. Among authors: navratil t. Drugs. 2024 Jan;84(1):83-97. doi: 10.1007/s40265-023-01973-7. Epub 2023 Dec 7. Drugs. 2024. PMID: 38060092 Free PMC article. Clinical Trial.
106 results